Which of the following describes the action of an agonist on a receptor.

Questions 32

ATI RN

ATI RN Test Bank

ATI Capstone Pharmacology Assessment 2 Questions

Question 1 of 5

Which of the following describes the action of an agonist on a receptor.

Correct Answer: C

Rationale: An agonist is a substance that binds to a receptor and triggers a biological response. By activating the receptor, an agonist mimics the action of the body's natural ligand that typically binds to the receptor. This activation may lead to a cascade of events within the cell, resulting in a specific physiological response. In contrast, antagonists block the receptor from being activated, while agonists work by binding to the receptor and initiating the desired response.

Question 2 of 5

Drug action that increase body activity

Correct Answer: A

Rationale: Stimulants are drugs that increase the body's activity levels. They work on the central nervous system to enhance alertness, attention, and energy. Examples of stimulants include caffeine, amphetamines, and nicotine. Stimulants can increase heart rate, blood pressure, and metabolism, leading to heightened physical and mental activity.

Question 3 of 5

The basic metric unit for the measurement of volume :

Correct Answer: C

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 4 of 5

If a bacteria were susceptible to both penicillin and erythromycin, then it would not be appropriate to treat the patients with both antibiotics at the same time because:

Correct Answer: A

Rationale: Penicillin is inactivated by erythromycin. Penicillin is a beta-lactam antibiotic which acts by inhibiting cell wall synthesis in bacteria. However, erythromycin is a macrolide antibiotic which can inactivate beta-lactam antibiotics like penicillin. When given together, erythromycin can inactivate penicillin, reducing its efficacy and potentially leading to treatment failure. Therefore, it is not appropriate to use both penicillin and erythromycin simultaneously to treat a bacterial infection.

Question 5 of 5

A patient undergoing chemotherapy for breast cancer asks why she is not receiving trastuzumab like her sister. Which response by the nurse is correct?

Correct Answer: D

Rationale: Trastuzumab is a targeted therapy used specifically for HER2-positive breast cancer. If the patient's cancer cells do not overexpress the HER2 receptor, trastuzumab will not be effective. The decision to use targeted therapy is based on the molecular characteristics of the tumor, not the patient's age, insurance coverage, or estrogen receptor status. The nurse should explain that targeted therapies are tailored to the specific biology of the cancer, and trastuzumab is only appropriate for HER2-positive tumors.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions